1-2 of 2
Mario Brown Arnold, MD
Close
Sort by
Journal Articles

90 y-Ibritumomab Tiuxetan Treatment for Relapsed and/or Refractory B-Cell Non- Hodgkin’S Lymphoma. Multi-Institutional Argentinian Study. An Update

Roberto Cacchione, MD, Jorge Milone, MD, Javier Bordone, MD, Elsa Nucifora, MD, Juan Dupont, MD, Guy Garay, Dardo Riveros, Alfredo Basso, MD, Silvia Rudoy, MD, Gustavo Milone, MD, Luis Palmer, MD, Daniel Argentieri, MD, Alicia Trouboul, MD, Maria Ardaiz, MD, Marcelo Iabstrebner, MD, Gonzalo Pombo, MD, Alicia Diaz, MD, Roberto Tur, MD, Carlos Chiattone, MD, Hugo Krupitzki, MD, Diana Lafalce, MD, Hugo Corradini, Mario Brown Arnold, MD, Carlos Cañellas, PHD, Marta Zerga, MD, Antonio Carrasco, MD, Fernando Bezares, MD
Journal: Blood
Blood (2008) 112 (11): 5009.
https://doi.org/10.1182/blood.V112.11.5009.5009
Published: 2008
Journal Articles

90 Y-Ibritumomab Treatment for Relapsed and/or Refractory B Cell Type Non-Hodgkin’s Lymphoma. Multiinstitutional Argentinian Study.

Roberto Cacchione, MD, Juan Dupont, MD, Jorge Milone, MD, Javier Bordone, MD, Guy Garay, MD, Maria Ardaiz, MD, Miguel Castro-Rios, MD, Virginia Prates, MD, Alfredo Basso, MD, Marcelo Iabstrebner, MD, Graciela Avila, MD, Alicia Diaz, MD, Daniel Argentieri, MD, Silvia Rudoy, MD, Alicia Trouboul, MD, Luis Palmer, MD, Gonzalo Pombo, MD, Silvina Rappaciotti, MD, Pedro Negri, MD, Diana Lafalse, MD, Leandro Riera, MD, Miguel de Tezanos-Pinto, MD, Dardo Riveros, MD, Mario Brown Arnold, MD, Antonio Carrasco, MD, Fernando Bezares, MD
Journal: Blood
Blood (2007) 110 (11): 4484.
https://doi.org/10.1182/blood.V110.11.4484.4484
Published: 2007